Preclinical Imaging Market Overview (2026–2030) With Industry Insights

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Preclinical Imaging Market Expected To Change From 2026 To 2030?

The preclinical imaging market size has witnessed strong expansion over recent years. It is anticipated to increase from $3.69 billion in 2025 to $3.93 billion in 2026, at a compound annual growth rate (CAGR) of 6.7%. The surge during the historical period can be ascribed to a greater reliance on animal models in biomedical research, an amplification of oncology and neurology studies, the rising acceptance of non-invasive imaging techniques, an increase in preclinical drug testing endeavors, and the availability of advanced imaging components.

The preclinical imaging market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $5.18 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is primarily driven by factors such as a heightened demand for real-time disease visualization, increasing financial commitments to translational research, the broadening scope of precision medicine studies, the expanding application of AI-assisted image analysis, and the greater deployment of sophisticated contrast agents. Key trends anticipated over this period encompass a wider uptake of multi-modal imaging platforms, an increased utilization of high-resolution imaging systems, deeper integration of imaging technologies with data analytics, an expansion of longitudinal studies for disease monitoring, and a sharpened emphasis on the accuracy of translational imaging.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

Which Drivers Are Supporting The Preclinical Imaging Market Growth?

The increasing prevalence of chronic diseases is projected to drive the expansion of the preclinical imaging market moving forward. Chronic diseases are defined as long-term health conditions that persist for an extended duration, typically three months or longer. These ailments frequently demand continuous medical management and can significantly impact an individual’s quality of life. For the identification of chronic diseases, preclinical imaging tools are utilized to visualize elements such as bone structure and lung function. They are also instrumental in studying chronic diseases to observe their progression and deepen understanding. For instance, in February 2024, the World Health Organization (WHO), a Switzerland-based agency overseeing international public health, stated that NCDs are responsible for 75% (three-quarters) of all global deaths. Therefore, the rise in chronic diseases is acting as a significant catalyst for the growth of the preclinical imaging market.

How Are Segments Identified Within The Preclinical Imaging Market Segment Framework?

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

Which Trends Are Expected To Impact The Preclinical Imaging Market?

Leading companies active in the preclinical imaging market are heightening their emphasis on releasing next-generation imaging systems to secure a competitive advantage. Next-generation imaging systems are defined as sophisticated and groundbreaking technologies that exceed current capacities by integrating cutting-edge features. For example, in September 2023, Revvity Inc., a US-based biotechnology company, introduced next-generation imaging systems crafted to propel innovation across various preclinical research applications. The recently unveiled products encompass the next-generation IVIS Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that effortlessly combines 2D optical and full 3D imaging. These imaging systems offer enhanced image-based functionalities and are engineered to optimize the imaging workflow.

Who Are The Companies Competing Within The Preclinical Imaging Market?

Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

Get The Full Preclinical Imaging Market Report:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Which Region Has The Greatest Market Share In The Preclinical Imaging Market?

North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Preclinical Imaging Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

Healthcare Cro Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

Crm Bpo Market Report

https://www.thebusinessresearchcompany.com/report/crm-bpo-global-market-report

Veterinary Cro And Cdmo Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795